HAEM5:ALK-positive anaplastic large cell lymphoma: Difference between revisions
| [unchecked revision] | [unchecked revision] |
Bailey.Glen (talk | contribs) |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:ALK-positive anaplastic large cell lymphoma}} | {{DISPLAYTITLE:ALK-positive anaplastic large cell lymphoma}} | ||
[[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | [[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | ||
| Line 15: | Line 14: | ||
Sumire Kitahara, MD, Cedars-Sinai, Los Angeles, CA | Sumire Kitahara, MD, Cedars-Sinai, Los Angeles, CA | ||
==WHO Classification of Disease== | ==WHO Classification of Disease== | ||
| Line 877: | Line 873: | ||
Cedars-Sinai, Los Angeles, CA | Cedars-Sinai, Los Angeles, CA | ||
[[Category:HAEM5]] | [[Category:HAEM5]] | ||
[[Category:DISEASE]] | [[Category:DISEASE]] | ||
[[Category:Diseases A]] | [[Category:Diseases A]] | ||